SPORENCT06875700
Beliefs, Attitudes, and Interest in Genetic Testing in Sarcoma Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria shortened, about 41 words Show 6 more changesShow less
- Enrollment increased: 300 → 400 participants
- Trial arms changed: 2 → 1
- Start date: Jul 9, 2024 to Jul 1, 2024
- Secondary endpoints: details revised at 1 of 1 entry
- Study description shortened, about 147 words
- Study title expanded, about 1 word
- Notable Primary and study completion dates: Jan 2029 to Aug 2027v3
- Minor Collaborators expanded, about 12 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Beliefs about the heritability of Leiomyosarcoma
Timeframe: up to 1 day from study enrollment
Secondary (1)
Interest in germline genetic testing
Arms and interventions
Patients with leiomyosarcoma
Electronic questionnaire assessing beliefs about the heritability of LMS and interest in genetic testing
Sites
1 site in 1 country
- Huntsman Cancer Institute at the University of UtahSalt Lake City, Utah, United States